文献速递泌尿生殖腹部PETMR

高危前列腺癌动态18F-氟甲基胆碱PET与动态增强MRI的定量评估

Quantitative assessment of dynamic 18F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer.
PubMed 文献 · Br J Radiol · 2018-11-14

本研究纳入41例高危前列腺癌患者,行前列腺动态增强MRI和动态18F-氟甲基胆碱PET,将影像与病理对照,分析定量与半定量参数及肿瘤/正常腺体比值,并评估两种检查参数间的相关性。结果显示肿瘤区多数PET与MRI参数高于正常组织,PET的K1与MRI的Ktrans和pei仅呈中度相关。

要点

  • 外周带肿瘤dPET的K1高于正常组织,肿瘤/正常腺体比值≥2有统计学意义。
  • 外周带及非外周带肿瘤DCE-MRI的in、kep、Ktrans和定量iAUC均高于对应正常组织。
  • dPET的K1与DCE-MRI的Ktrans和pei仅呈中度Spearman相关。

核心结论

  • 高危前列腺癌原发肿瘤的定量dPET与DCE-MRI参数不同于正常组织,但K1(dPET)与Ktrans和pei(DCE-MRI)仅呈中度相关,这些参数对PI-RADS v2的增量价值有待进一步研究。

研究设计与样本

  • 经机构批准的研究纳入41例同意行前列腺DCE-MRI和dPET的患者,MRI病灶按PI-RADS v2评分,PET局灶性病变予以记录,所有病灶与病理对照。

关键影像表现/征象

  • dPET上外周带肿瘤K1高于正常组织(p < 0.001),肿瘤/正常腺体比值≥2有统计学意义(p < 0.001)。
  • DCE-MRI上外周带和非外周带肿瘤的in、kep、Ktrans和定量iAUC均高于对应正常组织(p < 0.001)。
  • 外周带肿瘤Ktrans和pei的肿瘤/正常腺体比值≥1.5有统计学意义(p = 0.0019和0.0026)。

诊断标准与关键数值

  • 以病理为标准,共46个恶性病灶。
  • dPET外周带肿瘤K1的肿瘤/正常腺体比值≥2有统计学意义(p < 0.001)。
  • DCE-MRI外周带肿瘤Ktrans和pei的肿瘤/正常腺体比值≥1.5有统计学意义(p = 0.0019和0.0026)。

临床应用与阅片要点

  • 阅片时可关注dPET的K1及DCE-MRI的in、kep、Ktrans、定量iAUC在肿瘤与正常腺体间的差异。
  • 可计算肿瘤/正常腺体比值辅助判断,但原文未给出基于这些参数的诊断阈值或报告建议。

局限性

  • 原文结论指出这些参数对PI-RADS v2的增量价值有待进一步研究(warrants further investigation)。
  • 原文进展部分指出应进一步研究以确定这些参数对PI-RADS v2检出临床显著前列腺癌的潜在贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To describe dynamic 18F-flumethycholine PET (dPET) and dynamic contrast enhancement MR (DCE MR) parameters in localized high-risk prostate cancer (PCa), and determine whether these differ from normal prostate. Furthermore, to determine whether a correlation exists between dPET and DCE MR parameters.

METHODS:: 41 consenting patients who underwent prostate DCE MR and dPET were included in this institutionally approved study. Intraprostatic lesions on MR were assigned a PI-RADS v2 score, and focal lesions on PET were documented. All lesions were correlated with pathology. Quantitative and semi-quantitative DCE MR and two-tissue compartmental model dPET parameters were determined and tumor-to-normal gland ratios (T/N) for these parameters were calculated. Finally, dPET and DCE MR correlation was estimated using Spearman correlation coefficients.

RESULTS:: There were 46 malignant lesions per standard of reference. On dPET, peripheral zone (PZ) tumors had higher K1 (p < 0.001), and a T/N ratio ≥2 was significant (p < 0.001). On DCE MR, the parameters in, kep, Ktrans and quantitative iAUC were higher for PZ and non-PZ tumors than corresponding normal tissue (p < 0.001); for PZ tumors, a T/N ratio ≥ 1.5 for Ktrans and pei was significant (p = 0.0019 and 0.0026, respectively). Moderate Spearman correlation (0.40 < ρ < 0.59) was found between dPET K1 and DCE MR Ktrans and pei.

CONCLUSION:: In patients with high-risk PCa, quantitative dPET and DCE-MR parameters in primary tumors differ from normal tissue. Only moderate correlation exists between K1 (dPET) and Ktrans and pei (DCE MR). The incremental value of any of these parameters to PI-RADS v2 warrants further investigation.

ADVANCES IN KNOWLEDGE:: Unique quantitative and semi-quantitative FCH PET/MR parameters in PCa differ from normal gland, and should be further investigated to determine their potential contribution to PI-RADS v2 in the detection of clinically significant PCa.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Tau N, Berlin A, Yeung I, et al. Quantitative assessment of dynamic 18F-flumethycholine PET and dynamic contrast enhanced MRI in high risk prostate cancer. Br J Radiol. 2018. PMID: 30383459. doi:10.1259/bjr.20180568

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。